Targazyme, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation (NCT01983761) | Targazyme, Inc. | 2013-11-01 |
Track Targazyme, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.